Search
Search Results
- Publication:
- Washington, D.C. : AARP Public Policy Institute, c2008
- Subject(s):
- Community Participation
Delivery of Health Care
Evidence-Based Medicine
Consumer Behavior
Cost-Benefit Analysis
Decision Making
Patient Participation
Patient Satisfaction
Quality of Health Care
Humans
United States
- Publication:
- Washington, D.C. : AARP Public Policy Institute, c2009
- Subject(s):
- Community Health Services
Home Care Services -- economics
Medicaid -- economics
Cost-Benefit Analysis
Long-Term Care -- economics
State Government
Humans
United States
- Publication:
- Washington, D.C. : AARP Public Policy Institute, c2011
- Subject(s):
- Clinical Trials as Topic
Patient Selection
Randomized Controlled Trials as Topic
Aged
Aged, 80 and over
Chronic Disease
Cost-Benefit Analysis
Frail Elderly
Sample Size
Selection Bias
Humans
United States
- Publication:
- Washington, D.C. : National Health Policy Forum, [2006]
- Subject(s):
- Drug Industry -- economics
Vaccines -- supply & distribution
Cost-Benefit Analysis
Economic Competition
Government Regulation
Health Care Sector
Health Policy -- economics
Vaccination -- economics
Vaccines -- economics
Humans
United States
- Publication:
- Washington, D.C. : George Washington University, 2006
- Subject(s):
- Medical Records Systems, Computerized -- utilization
Cost-Benefit Analysis
Delivery of Health Care
Diffusion of Innovation
Health Care Surveys
Insurance Carriers
Humans
United States
United States. Department of Veterans Affairs
- Publication:
- Washington, D.C. : George Washington University, [2006]
- Subject(s):
- Cost-Benefit Analysis
Evidence-Based Medicine
Insurance Coverage -- economics
Technology Assessment, Biomedical
Formularies as Topic
Medicaid -- economics
Medicare -- economics
Private Sector
State Government
Humans
United Kingdom
United States
United States. Agency for Healthcare Research and Quality.
Blue Cross Association.
Blue Shield Association.
Centers for Medicare & Medicaid Services (U.S.)
National Institute for Health and Clinical Excellence (Great Britain)
- Author(s):
- Weiner, Janet, author
Linas, Benjamin, author
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, September 2018
- Subject(s):
- Cost-Benefit Analysis
Hepatitis C -- diagnosis
Mass Screening -- economics
Eligibility Determination
Health Policy
Hepatitis C -- drug therapy
Insurance Coverage -- economics
Mass Screening -- trends
Medicaid -- economics
Sofosbuvir -- economics
Sofosbuvir -- therapeutic use
Practice Guidelines as Topic
Humans
United States
Centers for Disease Control and Prevention (U.S.)
- Publication:
- Oakland, Calif. : California HealthCare Foundation, c2005
- Subject(s):
- Chronic Disease
Patient Care Management -- methods
Telephone
Communication
Cost-Benefit Analysis
Counseling
Patient Education as Topic
Process Assessment (Health Care)
Program Evaluation
Social Support
Telephone -- statistics & numerical data
Humans
United States
- Publication:
- Oakland, Calif. : California HealthCare Foundation, [2009]
- Subject(s):
- Comparative Effectiveness Research
Cost-Benefit Analysis
Decision Making
Insurance Coverage
Insurance, Health -- economics
Leadership
Medicare
Outcome Assessment (Health Care)
Public Opinion
Humans
California
- Publication:
- Washington, D.C. : George Washington University, [2008]
- Subject(s):
- Genetic Testing
Insurance Coverage
Pharmacogenetics -- economics
Pharmacogenetics -- trends
Information Management
Cost-Benefit Analysis
Drug Industry
Health Policy
Health Services Accessibility
Health Services Research
Insurance, Pharmaceutical Services
Pharmaceutical Preparations
Pharmacogenetics -- ethics
Safety
Humans
United States
- Author(s):
- Lindrooth, Richard C., author
Yakusheva, Olga, author
Fairman, Julie, author
Weiner, Janet, author
Naylor, Mary D., author
Pauly, Mark V., author
- Publication:
- [Philadelphia, Penna.] : Leonard Davis Institute of Health Economics, October 2015
- Subject(s):
- Cost-Benefit Analysis
Economics, Nursing
Health Care Costs
Nursing Staff, Hospital -- economics
Outcome Assessment (Health Care)
Quality of Health Care -- economics
Education, Nursing, Baccalaureate -- economics
Medicare -- economics
Nurses
Nurse's Role
Nursing Staff, Hospital -- education
Personnel Staffing and Scheduling
Reimbursement Mechanisms -- economics
Humans
United States
United States.
- Author(s):
- Yakusheva, Olga, author
Lindrooth, Richard C., author
Weiner, Janet, author
Spetz, Joanne, author
Pauly, Mark V., author
- Publication:
- [Philadelphia, Pennsylvania] : Leonard Davis Institute of Health Economics, November 2015
- Subject(s):
- Cost-Benefit Analysis
Medicare -- economics
Nurses
Nurse's Role
Nursing Staff, Hospital -- economics
Outcome Assessment (Health Care)
Cross Infection -- economics
Health Care Costs
Health Care Reform -- legislation & jurisprudence
Patient Readmission -- economics
Patient Readmission -- legislation & jurisprudence
Quality Indicators, Health Care
Quality of Health Care
Reimbursement, Incentive
Value-Based Purchasing
Humans
United States
United States.
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 7, 2017
- Subject(s):
- Arthritis, Rheumatoid -- drug therapy
Arthritis, Rheumatoid -- immunology
Immunologic Factors -- therapeutic use
Abatacept -- therapeutic use
Adalimumab -- therapeutic use
Antirheumatic Agents -- adverse effects
Antirheumatic Agents -- therapeutic use
Certolizumab Pegol -- therapeutic use
Cost-Benefit Analysis
Drug Therapy, Combination
Etanercept -- therapeutic use
Immunologic Factors -- adverse effects
Infliximab -- therapeutic use
Interleukin-6 -- antagonists & inhibitors
Janus Kinase Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Rituximab -- therapeutic use
Tumor Necrosis Factors -- antagonists & inhibitors
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 8, 2017
- Subject(s):
- Antibodies, Monoclonal -- therapeutic use
Dermatitis, Atopic -- drug therapy
Interleukin-4 Receptor alpha Subunit -- antagonists & inhibitors
Phosphodiesterase 4 Inhibitors -- therapeutic use
Antibodies, Monoclonal -- adverse effects
Cost-Benefit Analysis
Cyclosporine -- therapeutic use
Phosphodiesterase 4 Inhibitors -- adverse effects
Phototherapy
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 8, 2017
- Subject(s):
- Abuse-Deterrent Formulations -- economics
Abuse-Deterrent Formulations -- statistics & numerical data
Analgesics, Opioid -- economics
Analgesics, Opioid -- therapeutic use
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- prevention & control
Prescription Drug Diversion -- statistics & numerical data
Comparative Effectiveness Research
Cost-Benefit Analysis
Delayed-Action Preparations -- economics
Delayed-Action Preparations -- therapeutic use
Drug Compounding -- economics
Drug Overdose -- mortality
Insurance Coverage -- economics
Insurance, Pharmaceutical Services -- economics
Opioid-Related Disorders -- epidemiology
Humans
United States
- Publication:
- Chestnut Hill, MA : Center for Retirement Research at Boston College, [2008]
- Subject(s):
- Consumer Behavior
Health Benefit Plans, Employee -- statistics & numerical data
Insurance Coverage -- statistics & numerical data
Aged
Cost-Benefit Analysis
Employer Health Costs -- statistics & numerical data
Health Benefit Plans, Employee -- economics
Income
Humans
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, April 15, 2014
- Subject(s):
- Comparative Effectiveness Research
Hepatitis C, Chronic -- drug therapy
Heterocyclic Compounds, 3-Ring -- therapeutic use
Sulfonamides -- therapeutic use
Uridine Monophosphate -- analogs & derivatives
Uridine Monophosphate -- therapeutic use
Antiviral Agents -- economics
Antiviral Agents -- therapeutic use
Cost-Benefit Analysis
Drug Costs
Drug Therapy, Combination
Genotype
Hepatitis C -- economics
Hepatitis C -- genetics
Heterocyclic Compounds, 3-Ring -- adverse effects
Heterocyclic Compounds, 3-Ring -- economics
Insurance Coverage
Interferon-alpha -- therapeutic use
Oligopeptides -- therapeutic use
Polyethylene Glycols -- therapeutic use
Proline -- analogs & derivatives
Proline -- therapeutic use
Protease Inhibitors -- economics
Protease Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Ribavirin -- therapeutic use
Sulfonamides -- adverse effects
Technology Assessment, Biomedical
Treatment Outcome
Uridine Monophosphate -- adverse effects
Uridine Monophosphate -- economics
Value-Based Purchasing
Humans
United States
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, July 2014
- Subject(s):
- Analgesics, Opioid -- therapeutic use
Buprenorphine -- therapeutic use
Comparative Effectiveness Research
Delivery of Health Care
Health Policy
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Opiate Substitution Treatment -- economics
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- rehabilitation
Analgesics, Opioid -- administration & dosage
Analgesics, Opioid -- adverse effects
Budgets
Cohort Studies
Cost-Benefit Analysis
Counseling
Criminal Law
Drug Combinations
Drug Costs
Health Services Accessibility
Insurance Coverage
Medicaid
Medicare
Patient Care Team
Patient-Centered Care
Practice Guidelines as Topic
Treatment Outcome
Humans
New England
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Cunningham, Courtney, author
Pearson, Steven D., author
Kazi, Dhruv S., author
Coxson, Pamela G., author
Moran, Andrew E., author
Penko, Joanne, author
Guzman, David, author
Bibbins-Domingo, Kirsten, author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, November 24, 2015
- Subject(s):
- Anticholesteremic Agents -- therapeutic use
Azetidines -- therapeutic use
Enzyme Inhibitors -- therapeutic use
Hypercholesterolemia -- therapy
Hyperlipoproteinemia Type II -- prevention & control
Proprotein Convertases -- economics
Serine Endopeptidases -- economics
Cholesterol, LDL
Cost-Benefit Analysis
Decision Support Techniques
Drug Costs
Drug Resistance
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Technology Assessment, Biomedical
Treatment Outcome
Value-Based Purchasing
Humans
New England
United States
- Author(s):
- Ollendorf, Daniel A., author
Ollendorf, Daniel A., author
Tarlochan Sandhu, Alexander, author
Chapman, Rick, author
Heidenreich, Paul A., author
Russo, Elizabeth, author
Shore, Karen K., author
Synnott, Patricia, author
Travers, Karin, author
Weissberg, Jed, author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, December 1, 2015
- Subject(s):
- Angiotensin II Type 1 Receptor Blockers -- administration & dosage
Antihypertensive Agents -- administration & dosage
Blood Pressure Monitoring, Ambulatory -- instrumentation
Blood Pressure Monitoring, Ambulatory -- methods
Heart Failure -- diagnosis
Heart Failure -- drug therapy
Neprilysin -- administration & dosage
Tetrazoles -- administration & dosage
Valsartan -- administration & dosage
Angiotensin II Type 1 Receptor Blockers -- economics
Antihypertensive Agents -- economics
Cost-Benefit Analysis
Drug Combinations
Drug Costs
Neprilysin -- antagonists & inhibitors
Neprilysin -- economics
Outcome and Process Assessment (Health Care)
Tetrazoles -- economics
Valsartan -- economics
Humans
United States
